|
1
|
Umetani M, Domoto H, Gormley AK, Yuhanna
IS, Cummins CL, Javitt NB, Korach KS, Shaul PW and Mangelsdorf DJ:
27-Hydroxycholesterol is an endogenous SERM that inhibits the
cardiovascular effects of estrogens. Nat Med. 13:1185–1192. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DuSell CD, Umetani M, Shaul PW,
Mangelsdorf DJ and McDonnell DP: 27-Hydroxycholesterol is an
endogenous selective estrogen receptor modulator. Mol Endocrinol.
22:65–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
DuSell CD, Nelson ER, Wang X, Abdo J,
Mödder UI, Umetani M, Gesty-Palmer D, Javitt NB, Khosla S and
McDonnell DP: The endogenous selective estrogen receptor modulator
27-hydroxycholesterol is a negative regulator of bone homeostasis.
Endocrinology. 151:3675–3685. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nelson ER, DuSell CD, Wang X, Howe MK,
Evans G, Michalek RD, Umetani M, Rathmell JC, Khosla S,
Gesty-Palmer D and McDonnell DP: The oxysterol,
27-hydroxycholesterol links cholesterol metabolism to bone
homeostasis through its actions on the estrogen and liver X
receptors. Endocrinology. 152:4691–4705. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cruz P, Torres C, Ramírez ME, Epuñán MI,
Valladares LE and Sierralta WD: Proliferation of human mammary
cancer cells exposed to 27-hydroxycholesterol. Exp Ther Med.
1:531–536. 2010.PubMed/NCBI
|
|
6
|
Torres CG, Ramírez ME, Cruz P, Epuñan MI,
Valladares LE and Sierralta WD: 27hydroxycholesterol induces the
transition of MCF7 cells into a mesenchymal phenotype. Oncol Rep.
26:389–397. 2011.PubMed/NCBI
|
|
7
|
Zhou G, Dada LA, Wu M, Kelly A, Trejo H,
Zhou Q, Varga J and Sznajder JI: Hypoxia-induced alveolar
epithelial-mesenchymal transition requires mitochondríal ROS and
hypoxia-inducible factor I. Am J Physiol Lung Cell Mol Physiol.
297:L1120–L1130. 2009.PubMed/NCBI
|
|
8
|
Boveris A and Chance B: The mitochondrial
generation of hydrogen peroxide: general properties and effect of
hyperbaric oxygen. Biochem J. 134:707–716. 1973.PubMed/NCBI
|
|
9
|
Nemoto S, Takeda K, Yu Z-X, Ferrans VJ and
Finkel T: Role for mitochondrial oxidants as regulators of cellular
metabolism. Mol Cell Biol. 20:7311–7318. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nicholls DG and Budd SU: Mitochondria and
neuronal survival. Physiol Rev. 80:315–360. 2000.PubMed/NCBI
|
|
11
|
Werner E and Werb Z: Integrins engage
mitochondrial function for signal transduction by a mechanism
dependent on Rho GTPases. J Cell Biol. 158:357–368. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Giannoni E, Bianchini F, Calorini L and
Chiarugi P: Cancer associated fibroblasts exploit reactive oxygen
species through a proinflammatory signature leading to epithelial
mesenchymal transition and stemness. Antioxid Redox Signal.
14:2361–2371. 2011. View Article : Google Scholar
|
|
13
|
Li Z, Shi K, Guan L, Cao T, Jiang Q, Yang
Y and Xu C: ROS leads to MnSOD upregulation through ERK2
translocation and p53 activation in selenite-induced apoptosis of
NB4 cells. FEBS Lett. 584:2291–2297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bakthavatchalu V, Dey S, Xu Y, Noel T,
Jungsuwadee P, Holley AK, Dhar SK, Batinic-Haberle I and St Clair
DK: Manganese superoxide dismutase is a mitochondrial fidelity
protein that protects Polγ against UV-induced inactivation.
Oncogene. Sep 12–2011.(Epub ahead of print). View Article : Google Scholar
|
|
15
|
Chen M, Ni J, Chang HC, Lin CY, Muyan M
and Yeh S: CCDC62/ERAP75 functions as a coactivator to enhance
estrogen receptor beta-mediated transactivation and target gene
expression in prostate cancer cells. Carcinogenesis. 30:841–850.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Monje P and Boland R: Subcellular
distribution of native estrogen receptor alpha and beta isoforms in
rabbit uterus and ovary. J Cell Biochem. 82:467–479. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fox EM, Davis RJ and Shupnik MA: ERβ in
breast cancer -onlooker, passive player or active protector?
Steroids. 73:1039–1051. 2008.
|
|
18
|
Yager ID and Chen JQ: Mitochondrial
estrogen receptors-new insights into specific functions. Trends
Endocrinol Metab. 18:89–91. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Klinge CM: Estrogenic control of
mitochondrial function and biogenesis. J Cell Biochem.
105:1342–1351. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Psarra AM and Sekeris CE: Steroid and
thyroid hormone receptors in mitochondria. IUBMB Life. 60:210–223.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Simpkins JW, Yang SH, Sarkar SN and Pearce
V: Estrogen actions on mitochondria: physiological and pathological
implications. Mol Cell Endocrinol. 290:51–59. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hsieh YC, Yu HP, Suzuki T, Choudhry MA,
Schwacha MG, Bland KI and Chaudry IH: Upregulation of mitochondrial
respiratory complex IV by estrogen receptor-beta is critical for
inhibiting mitochondrial apoptotic signaling and restoring cardiac
functions following trauma-hemorrhage. J Mol Cell Cardiol.
41:511–521. 2006. View Article : Google Scholar
|
|
23
|
Chen JQ, Russo PA, Cooke C, Russo IH and
Russo J: ERbeta shifts from mitochondria to nucleus during
estrogen-induced neoplastic transformation of human breast
epithelial cells and is involved in estrogen-induced synthesis of
mitochondrial respiratory chain proteins. Biochim Biophys Acta.
1773:1732–1746. 2007. View Article : Google Scholar
|
|
24
|
Bakthavatchalu V, Dey S, Xu Y, Noel T,
Jungsuwadee P, Holley AK, Dhar SK, BatinicHaberle I, St Chen JQ,
Delannoy M, Cooke C and Yager ID: Mitochondrial localization of
ERalpha and ERbeta in human MCF7 cells. Am J Physiol Endocrinol
Metab. 286:E1011–E1022. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Madureira PA, Varshochi R, Constantinidou
D, Francis RE, Coombes RC, Yao KM and Lam EW: The Forkhead box M1
protein regulates the transcription of the estrogen receptor alpha
in breast cancer cells. J Biol Chem. 281:25167–25176. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Millour J, Constantinidou D, Stavropoulou
AV, Wilson MS, Myatt SS, Kwok JM, Pedram A, Razandi M, Wallace DC
and Levin ER: Functional estrogen receptors in the mitochondria of
breast cancer cells. Mol Biol Cell. 17:2125–2137. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Francis RE, Myatt SS, Krol J, Hartman J,
Peck B, McGovern UB, Wang J, Guest SK, Filipovic A, Gojis O,
Palmieri C, Peston D, Shousha S, Yu Q, Sicinski P, Coombes RC and
Lam EW: FoxM1 is a downstream target and marker of HER2
overexpression in breast cancer. Int J Oncol. 35:57–68.
2009.PubMed/NCBI
|
|
28
|
Bektas N, Haaf A, Veeck J, Wild PI,
Lüscher-Firzlaff J, Hartmann A, Knüchel R and Dahl E: Tight
correlation between expression of the Forkhead transcription factor
FOXMi and HER2 in human breast cancer. BMC Cancer. 8:422008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sivanandan K, Coombes RC, Medema RH,
Hartman J, Lykkesfeldt AE and Lam EW: FOXM1 is a transcriptional
target of ERalpha and has a critical role in breast cancer
endocrine sensitivity and resistance. Oncogene. 29:2983–2995. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sierralta WD, Boenig I and Thole HH:
Immunogold labelling of estradiol receptor in MCF 7 cells. Cell Tis
Res. 279:445–452. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Flohé L and Otting F: Superoxide dismutase
assays. Methods Enzymol. 105:93–104. 1984.
|
|
32
|
Powers SK, Lieu FK, Criswell D and Dodd S:
Biochemical verification of quantitative histochemical analysis of
succinate dehydrogenase activity in skeletal muscle fibres.
Histochem J. 25:491–496. 1993. View Article : Google Scholar
|
|
33
|
Giannoni E, Buricchi F, Grimaldi G, Parri
M, Cialdai F, Taddei ML, Raugei G, Ramponi G and Chiarugi P: Redox
regulation of anoikis: reactive oxygen species as essential
mediators of cell survival. Cell Death Differ. 15:867–878. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Prasanthi JRP, Larson T, Schommer J and
Ghribi O: Silencing GADD153/CHOP gene expression protects against
Alzheimer’s disease-like pathology induced by 27-hydroxycholesterol
in rabbit hippocampus. PLoS One. 6:e26420 View Article : Google Scholar : 2011.PubMed/NCBI
|
|
35
|
Nilsson S and Gustafsson JA: Estrogen
receptors: therapies targeted to receptor subtypes. Clin Pharmacol
Ther. 89:44–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao C, Dahlman-Wright K and Gustafsson
JA: Estrogen signaling via estrogen receptors. J Biol Chem.
285:39575–39579. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kwok JM, Peck B, Monteiro U, Schwenen HD,
Millour J, Coombes RC, Myatt SS and Lam EW: FOXM1 confers acquired
cisplatin resistance in breast cancer cells. Mol Cancer Res.
8:24–34. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chua PJ, Yip GW and Bay BH: Cell cycle
arrest induced by hydrogen peroxide is associated with modulation
of oxidative stress related genes in breast cancer cells. Exp Biol
Med. 234:1086–1094. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Karadedou CT: Regulation of the FOXM1
transcription factor by the estrogen receptor alpha at the protein
level in breast cancer. Hippokratia. 10:128–132. 2006.PubMed/NCBI
|
|
40
|
Zhang N, Wei P, Gong A, Chiu WT, Lee HT,
Colman H, Huang H, Xue J, Liu M, Wang Y, Sawaya R, Xie K, Yung WK,
Medema RH, He X and Huang S: FoxM1 promotes R-catenin nuclear
localization and controls Wnt target-gene expression and glioma
tumorigenesis. Cancer Cell. 20:427–442. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Steele RJ, Eremin O, Brown M and Hawkins
RA: A high macrophage content in human breast cancer is not
associated with favourable prognostic factors. Br J Surg.
71:456–458. 1984. View Article : Google Scholar : PubMed/NCBI
|
